RT @smexcardiologia: Sin duda, más evidencia para continuar las recomendaciones de @smexcardiologia y otras sociedades, para no suspender e…
Large European cohort of COVID Pts confirms high risk of cardiovascular conditions, doesn’t find any ACEI/ARB effect. https://t.co/5awJw50geS
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
Sin duda, más evidencia para continuar las recomendaciones de @smexcardiologia y otras sociedades, para no suspender el tratamiento con IECA/ARA-II. Más información en: https://t.co/aJ6Bn1V7zN #SocMexCardio @rodrigogopar @mitrehit @LuisBaeza15 @drdargara
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/IUF0vo1ToW @ivanovich13 @torresviera @SIAC_cardio @CardiologiaSVC @InfectiousDz @HeartOTXHeartMD @gonzaeperez @JCosinSales @Cardio_delaGuia @igormorr @ernestocardio @Lgueva
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @DrEkstrom: Vore trevligt om det kunde bli en lika fet kvällstidningsrubrik om att det är säkert, som när det kom spekulationer om att d…
@Barnard2018 ho il sospetto che in questi giorni ci sia un particolare accanimento contro un farmaco che è stato considerato sicuro per sessanta anni... sono serie queste considerazioni? https://t.co/8RRWqj3bCF
Efermedad cardiovascular , Farmacoterapia in COVID 19 NEJM https://t.co/WwfLMP6gRe
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @JoseSubiza: Un estudio publicado en el NEJM sugiere que las mujeres son más resistentes a Covid-19 que los hombres. Para los autores, l…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
swoją drogą.. pacjenci, którzy mają problemy sercowo-naczyniowe, zazwyczaj mają zdec. utrudnione leczenie przeróżnych innych schorzeń, nie tylko zw. z chorobą zakaźną/wirus M. zd. konkluzja tych obserwacji wydaje się dość przewidywalna https://t.co/rR80PI4
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
糖尿病や高血圧自体は新型コロナウイルス感染症COVID-19重症化の危険因子ではない可能性 65歳以上、冠動脈疾患、心不全、不整脈、COPD、喫煙 が危険因子https://t.co/FY8IIYrZpj
8910 patients with COVID-19: ✔️Female sex, use of ACE inhibitors, use of statins ➡️ better chance of survival to hospital discharge. https://t.co/lwnYdGPfun
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @RostronTony: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM…BP control probably one of the most important publ…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM caliente... @NEJM 1/4 artículos hoy sobre este maravilloso eje RAA y COVID y que creen que Renina angiotensina y aldosterona son hormonas ! Abro hilo https://t.co/otpfq7E53r
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DrEkstrom: Vore trevligt om det kunde bli en lika fet kvällstidningsrubrik om att det är säkert, som när det kom spekulationer om att d…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @ABsteward: In this large population based study @NEJM Using database from 169 hospitals in Asia, Europe, and North America"~9000 patien…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @jvillacastin: Our study confirmed previous observations suggesting that underlying cardiovascular disease is associated with an increas…
RT @jvillacastin: Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with in…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @kimitakatajimi: ACE阻害薬(アンジオテンシン変換酵素阻害、ARB(アンジオテンシンII受容体拮抗薬)は、COVID-19の死亡率を上げない。 ........ Cardiovascular Disease, Drug Therapy, and Mort…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @jvillacastin: Our study confirmed previous observations suggesting that underlying cardiovascular disease is associated with an increas…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with in-hospital death in this clinical context. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/Md8hTwsc3
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Our study confirmed previous observations suggesting that underlying cardiovascular disease is associated with an increased risk of in-hospital death among patients hospitalized with Covid-19. https://t.co/FQRieB6sih
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Il y a près de 20.000 patients dans ces 3 études, et 23.000 environs avec les 2 études précédentes. Ce n'est pas encore une preuve, mais on peut dire à priori que ARA2 et IEC n’entraînent pas de risque majeur en cas de COVID19 🔜 étude 3 : https://t.co/fhH
RT @DanielJDrucker: “Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in #COVIDー19 https://t.co/MjtRmL9Cqd
@gabrielperez126 Ahora mira este otro estudio, también de hoy: "Nuestros resultados no confirmaron preocupaciones anteriores con respecto a una posible asociación nociva de inhibidores de la ECA o BRA con muerte intrahospitalaria en en el contexto clínico
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/WTno5fZHbU
Changing thoughts regarding ACEI/ARB in #COVID19 .@NJACC. https://t.co/UhyHzqaqUl
RT @CharlieTomson: Three papers confirming what @RenalAssoc @escardio and others said all along: RAS inhibitors do not make people more lik…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
It’s hard to interpret. We accept all the conditions listed are indeed putting folk at greater risk, but don’t trust positive drug signal. Do you think their ‘beneficial effect’ is simply bc they are controlling their disease of indication but some how sta
@OutbreakJake what you said
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
ACE阻害薬(アンジオテンシン変換酵素阻害、ARB(アンジオテンシンII受容体拮抗薬)は、COVID-19の死亡率を上げない。 ........ Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/sHxQmYfS0y
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DrEkstrom: Vore trevligt om det kunde bli en lika fet kvällstidningsrubrik om att det är säkert, som när det kom spekulationer om att d…
RT @ProfJDChalmers: Landmark day in the epidemiology of COVID- the day that an observational study shows an extreme beneficial effect of st…
RT @drbenekli: Factors associated with an increased risk of in-hospital death from #COVID19 were age > 65 years, coronary artery disease, h…
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
A bit odd to call people having legitimate concern, based on a drug's known actions "hysteria"
RT @Azeem_Majeed: Another reason to stop smoking. Risk factors for death in hospital patients with Covid-19 in an international study publi…
#COVID19. Some more evidences/studies against use of hydroxychloroquine as prophylaxis or treatment (except under emergency use for particular cases): https://t.co/HAyMivv22E and https://t.co/Ucjr9S64Od @AnooBhu @ICMRDELHI
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @Babak_Javid_Lab: Statins and ACE-I associated with decreased mortality for Covid (although CVD itself is risk factor for increased mort…
RT @GarnachoJose: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/HQOYHLohN0
This is reassuring. No increased risk of in-hospital death was found to be associated with the use of ACE inhibitors (2.1% vs. 6.1%; odds ratio, 0.33; 95% CI, 0.20 to 0.54) or the use of ARBs (6.8% vs. 5.7%; odds ratio, 1.23; 95% CI, 0.87 to 1.74) @NEJM ht
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Landmark day in the epidemiology of COVID- the day that an observational study shows an extreme beneficial effect of statins (or ACE-I)-published today in NEJM. Just like the observational studies that show statins cure COPD, asthma, pneumonia, sepsis...
Here is a strong evidence of ACEi, harmless to #COVID__19 patients. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/e8KmJIgr3s
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Important study showing #statins and #ACE inhibitors protective - ARBs possibly increase risk from #COVID19 but non-significant. Keep taking you #hypertension meds! https://t.co/K7k3iRqZsb https://t.co/f13EuuXfCI
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Covid-19, has been shown to establish itself in the host through the use of angiotensin-converting enzyme 2 (ACE2) as its cellular receptor.8 ACE…https://t.co/3HkLq8hySc
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DrYukselUrun: Data from 8910 patients 👇 "ACE-I/ARBs were not associated with an increased risk of in-hospital death but the underlying…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…